Diversified Healthcare Trust (DHC)
Official siteREAL ESTATE • REIT - HEALTHCARE FACILITIES • NASDAQ
Market Cap: $1.72B
Last updated: Nov 17, 2026 at 4:33 PM ET
Diversified Healthcare Trust (DHC) Statistics
Diversified Healthcare Trust (DHC) has a market cap of $1.72B and a P/FFO of 10.4x on its 2026 FFO estimate. Its net debt of $2.29B equals 133.19% of its market cap. It kept -10.29% of revenue as net income over the last 12 months.
Total Valuation
Enterprise value is 133.19% above the market cap, as debt exceeds cash.
| Market Cap | $1.72B |
|---|---|
| Enterprise Value | $4.02B |
| Latest price (Nov 17, 2026) | $7.16 |
Key Dates
The next earnings report is expected on Feb 22, 2027, covering the quarter ending Dec 31, 2026. The last ex-dividend date was Oct 19, 2026.
| Next Earnings Date | Feb 22, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 2, 2026 |
| Last Ex-Dividend Date | Oct 19, 2026 |
| Last Payment Date | Nov 12, 2026 |
| Fiscal Year End | December |
Valuation Ratios
P/FFO is 10.4x on the 2026 FFO estimate of $0.69 a share. Its year-end P/S ranged from 0.1x to 4.2x from 2016 to 2025.
| P/FFO (2026 estimate) | 10.4x |
|---|---|
| P/S Ratio | 1.2x |
| Forward P/S | 1.2x |
| P/B Ratio | 1.1x |
| P/TBV Ratio | 1.1x |
| P/OCF Ratio | 31.9x |
Enterprise Valuation
Counting debt and cash, the company is valued at 16.3x EBITDA.
| EV / Sales | 2.7x |
|---|---|
| EV / EBITDA | 16.3x |
Price Statistics
The stock is up 54.92% over 52 weeks and trades 6.41% below its 50-day average.
| Beta (1Y) | 0.64 |
|---|---|
| 52-Week Change | +54.92% |
| 1-Month Change | -2.85% |
| 3-Month Change | -11.48% |
| 6-Month Change | -16.46% |
| 5-Year Change | +113.74% |
| 10-Year Change | -63.42% |
| Total Return (1Y) | +55.78% |
| Total Return (3Y CAGR) | +51.28% |
| Total Return (5Y CAGR) | +18.80% |
| Return vs SPY (1Y) | +45.05% |
| Max Drawdown (1Y) | -27.08% |
| Max Drawdown (3Y) | -51.17% |
| Sharpe Ratio (1Y) | 1.20 |
| Correlation with SPY (1Y) | 0.24 |
| 50-Day Average | $7.65 |
| 200-Day Average | $7.85 |
| 52-Week Range | $4.32 to $9.65 |
| RSI (14 Days) | 39.2 |
| Average Volume (20 Days) | 1.81M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 400.45x current liabilities, and total debt is 1.57x shareholder equity.
| Current Ratio | 400.45x |
|---|---|
| Quick Ratio | 400.45x |
| Debt / Equity | 1.57x |
| Debt / EBITDA | 9.76x |
| Interest Coverage | -0.14x |
Returns and Efficiency
Return on invested capital is -0.58% over the last 12 months, against a 5-year average of 0.78%.
| Return on Equity (ROE) | -9.94% |
|---|---|
| Return on Assets (ROA) | -3.63% |
| Return on Invested Capital (ROIC) | -0.58% |
| Return on Capital Employed (ROCE) | -0.55% |
| ROE (5Y Average) | -8.49% |
| ROA (5Y Average) | -3.34% |
| ROIC (5Y Average) | 0.78% |
| Asset Turnover | 0.33x |
Scores
DHC has a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 5 of 9 |
|---|---|
| Piotroski Strength | Average |
Income Statement
FFO per share was $0.52 for 2025, the latest reported year. Revenue of $1.48B over the last 12 months is down 3.82% from the 12 months before.
| FFO Per Share (2025) | $0.52 |
|---|---|
| Revenue | $1.48B |
| Revenue Growth (YoY) | -3.82% |
| Gross Profit | $1.48B |
| Operating Income | -$33.95M |
| Pretax Income | -$180.75M |
| Net Income | -$152.14M |
| EBITDA | $246.29M |
| EBIT | -$22.92M |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 36.52% of the $4.19B in total assets.
| Cash and Equivalents | $110.66M |
|---|---|
| Total Debt | $2.40B |
| Net Debt | $2.29B |
| Net Debt Per Share | $9.52 |
| Working Capital | $130.62M |
| Shareholder Equity | $1.53B |
| Book Value Per Share | $6.35 |
| Tangible Book Value | $1.51B |
| Tangible Book Per Share | $6.28 |
| Total Assets | $4.19B |
| Total Liabilities | $2.66B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $118.66M of capital spending, operating cash flow left -$64.65M of free cash flow.
| Operating Cash Flow | $54.01M |
|---|---|
| Capital Expenditures | $118.66M |
| Free Cash Flow | -$64.65M |
| FCF Per Share | -$0.27 |
| Depreciation and Amortization | $269.21M |
| Dividends Paid | $9.68M |
| Share Repurchases | $2.78M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -2.30%, against a 5-year average of -7.63%.
| Gross Margin | 100.00% |
|---|---|
| Operating Margin | -2.30% |
| Pretax Margin | -12.22% |
| Net Margin | -10.29% |
| EBITDA Margin | 16.65% |
| EBIT Margin | -1.55% |
| FCF Margin | -4.37% |
| Operating Margin (5Y Average) | -7.63% |
| Net Margin (5Y Average) | -10.48% |
Growth
Revenue grew 6.21% a year over 3 years.
| Revenue Growth (3Y CAGR) | +6.21% |
|---|---|
| Revenue Growth (5Y CAGR) | -1.18% |
| Book Value Per Share Growth (2Y CAGR) | -15.77% |
| Tangible Book Per Share Growth (2Y CAGR) | -15.68% |
Dividends and Yields
DHC pays out 7.69% of 2025 FFO as dividends.
| Dividend Per Share (Annual) | $0.04 |
|---|---|
| Dividend Yield | 0.56% |
| Payment Schedule | Quarterly |
| Dividend Growth (3Y CAGR) | 0.00% |
| Dividend Growth (5Y CAGR) | +5.92% |
| Payout Ratio (2025 FFO) | 7.69% |
| FFO Yield (2025) | 7.26% |
| FCF Yield | -3.75% |
| Buyback Yield | 0.16% |
| Shareholder Yield | 0.72% |
Peer Position
Against 11 similar companies, DHC has the 9th highest P/FFO and the 10th highest P/S.
P/FFOPeer median 11.3x
P/S RatioPeer median 5.3x
ROICPeer median 4.21%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +19.51%
Dividend YieldPeer median 5.93%
| P/FFO | 10.4x vs 11.3x median |
|---|---|
| P/S Ratio | 1.2x vs 5.3x median |
| ROIC | -0.58% vs 4.21% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | -3.82% vs +19.51% median |
| Dividend Yield | 0.56% vs 5.93% median |
Analyst Forecast
FFO per share estimates imply 30.09% growth a year over the next 2 years. Consensus estimates put revenue growth at 0.29% a year over the next 2 fiscal years.
| FFO Per Share Growth Forecast (2Y CAGR) | +30.09% |
|---|---|
| Revenue Growth Forecast (2Y CAGR) | +0.29% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Overvalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About DHC
What is DHC's market cap?
Diversified Healthcare Trust has a market cap of $1.72B. Its enterprise value, which adds debt and subtracts cash, is $4.02B.
What is DHC's price to FFO ratio?
Diversified Healthcare Trust has a P/FFO of 10.4x on its 2026 FFO estimate.
How many shares of DHC are outstanding?
Diversified Healthcare Trust has 240.98M shares outstanding. The count is up 0.25% from a year earlier.
Does DHC pay a dividend?
Yes. Diversified Healthcare Trust pays $0.04 a share a year, a dividend yield of 0.56%.
How much debt does DHC have?
Diversified Healthcare Trust has $2.40B of total debt and $110.66M of cash and equivalents, a net debt position of $2.29B.
DHC pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors